@article{b55ded5b04494d38bf53f80707fb6afb,
title = "Incorporating economic evaluation into immunization decision making in Canada: A workshop",
author = "Langley, {Joanne M.} and Murray Krahn and Don Husereau and John Spika and Fisman, {David N.} and Ayman Chit and {Van Exan}, Rob",
note = "Funding Information: improving equity of access to vaccines, increasing coordination of safety monitoring, program planning and immunization registries, development of national goals and objectives and other aspects of implementation [5]. This was supported by a federal commitment of C$45 million over 5 years to strengthen a national collaboration framework and C$300 million over 3 years in the 2004 federal budget for an immunization trust to introduce four new vaccines [6]; another C$300 million 3-year trust was also funded in 2007 to support the introduction of HPV vaccines. The National Immunization Strategy accepted an analytic framework for immunization decision-making, in which cost-effectiveness is one of 13 information categories for consideration (FIGURE 1) [7]. In 2004, other national bodies were created to strengthen public health (the Public Health Agency of Canada and the Pan-Canadian Public Health Network), and a federal, provincial and territorial committee was established (the Canadian Immunization Committee) separate from NACI with the responsibility for planning and delivery of immunization programs, including economic considerations [2].",
year = "2014",
month = nov,
day = "1",
doi = "10.1586/14760584.2014.939637",
language = "English",
volume = "13",
pages = "1291--1296",
journal = "Expert Review of Vaccines",
issn = "1476-0584",
publisher = "Expert Reviews Ltd.",
number = "11",
}
